Agilon Health (NYSE:AGL) Stock Price Up 8.7% – What’s Next?

Agilon Health, Inc. (NYSE:AGL)’s stock price was up 8.7% during mid-day trading on Friday . The company traded as high as $128.10 and last traded at $131.7970. Approximately 142,459 shares traded hands during mid-day trading, a decline of 59% from the average daily volume of 350,382 shares. The stock had previously closed at $121.22.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on AGL shares. Benchmark reissued a “buy” rating and set a $95.00 target price (up from $13.00) on shares of Agilon Health in a research note on Thursday, May 21st. Weiss Ratings cut shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 27th. Deutsche Bank Aktiengesellschaft upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $33.00 to $49.00 in a research note on Thursday, May 7th. Citigroup reissued a “neutral” rating and set a $80.00 price target (up from $18.75) on shares of Agilon Health in a research report on Friday, May 15th. Finally, TD Cowen restated a “hold” rating and set a $55.00 target price (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Agilon Health has a consensus rating of “Hold” and an average target price of $64.00.

Agilon Health Trading Up 6.8%

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The company has a market capitalization of $2.16 billion, a price-to-earnings ratio of -6.00 and a beta of 2.98. The firm has a fifty day moving average price of $100.84 and a 200-day moving average price of $47.53.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The company had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.38 billion. As a group, equities analysts anticipate that Agilon Health, Inc. will post -3.5 EPS for the current year.

Institutional Trading of Agilon Health

A number of hedge funds have recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. grew its stake in shares of Agilon Health by 196.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock worth $13,812,000 after purchasing an additional 13,283,930 shares during the last quarter. AQR Capital Management LLC raised its holdings in Agilon Health by 1,346.6% during the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock worth $7,033,000 after purchasing an additional 9,505,837 shares during the last quarter. North Peak Capital Management LLC raised its holdings in Agilon Health by 10.8% during the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock worth $26,267,000 after purchasing an additional 3,715,460 shares during the last quarter. Voleon Capital Management LP boosted its position in Agilon Health by 5,519.2% during the third quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock valued at $2,823,000 after acquiring an additional 2,692,259 shares during the last quarter. Finally, UBS Group AG increased its holdings in Agilon Health by 250.7% in the fourth quarter. UBS Group AG now owns 3,395,366 shares of the company’s stock worth $2,339,000 after purchasing an additional 2,427,136 shares in the last quarter.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.